Together Pharma is an Israeli company with a big field in Uganda.
FACILITIES:
GACP-certified cultivation in Uganda
320,000 sq ft of greenhouses on 100 hectares of land.
NEWS & PARTNERSHIPS:
2018
The company announced a sales agreement with a Canadian company to sell 50 tons of cannabis inflorescences or 5 tons of cannabis oil to them. The companies will also collaborate in the field of R&D and promoting technologies in the medical cannabis sector.
The company signed a 51% JV with an undisclosed company for the production of up to 60 tons annually of medical cannabis from greenhouses outside of Israel in an area of up to 25 acres.
The company signed an agreement with Yamco-Yadpaz for the establishment of a cannabis greenhouse complex in a foreign country covering 1,5 hectares where YY will provide the company with irrigation, dripper, cooling and fertilizer systems from Netafim, ventilation systems and other required advanced technological systems to ensure suitable conditions that comply with the G.A.P. standard for growing medical cannabis.
The company signed a binding memorandum of principles for cooperation with Premier Dead Sea for the development, manufacturing and marketing of a line of care products combining Dead Sea minerals with CBD for an end product to be distributed and marketed to countries in which CBD compounds have been legalized and does not require a doctor’s prescription focusing on Europe and Canada. Together will build a factory to manufacture and process the joint products according to required standards.
The company made an order for cannabis seeds from one of the world’s leading cannabis suppliers in the Netherlands for its farm in Uganda.
The company signed a binding memorandum of understanding for collaboration with an entity in a European Union country for setting up greenhouses and a production facility of around 320,000 sq ft for the export of medical cannabis products with the company owning 51% of the JV.
The company signed a memorandum of understanding for the supply of cannabis products to a German company.
The company signed a binding memorandum of understanding to acquire 50,01% of a German company has a distribution agreement involving around 100 pharmacies as well a R&D license allowing the company to develop new strains of cannabis and genetics that will be exclusive IP. The German company now is examining different strains and their influences on various diseases.
2019
The company signed a memorandum of understanding with a company controlled by a Chinese corporation for setting up medical cannabis operations in China, which will be divided 50/50%. The Chinese company will invest 1 million USD and fund the activity establishment, at the company’s market cap on the agreement’s completion date. The JV will look into the CBD-based food, beverage, pharmaceutical and cosmetics product markets in China.
The company’s medical cannabis farm in Uganda has received a GACP-creditation and is building its own EU-GMP factory.
The company’s medical cannabis farm in Ashkelon received an IMC-GAP accreditation.
The company signed a binding agreement with Premier Dead Sea for the creation of a JV for the sale of cosmetics based on CBD that the company will own 51% of.
2022
Thanks to a partnership between Cantourage and Together Pharma, Together Pharma’s Glueberry OG cultivar will be distributed in Poland through selected pharmacies. This supply agreement consists of the importation of more than 500 kg of dried cannabis over 3 years starting in 2023. In Germany and the UK, the company is selling the Gluberry OG as well as a Power Plant cultivar.
The company received a license to import the Glueberry OG and Powerplant strains from Germany to the UK via Cantourage UK.